درباره این اپیزود

انگلیسی
ایالات متحده آمریکا

رونوشت 🔗

جستجوی اپیزودهای گذشته

اپیزودهای قبلی Transcribed را جستجو کن.

قسمت های دیگر در این پادکست

From starting and selling companies across three continents to backing the next wave of European biotech, Dr. Andreas Schmidt now sits at the intersection of founder, operator, and investor. In this episode, he explains why "venture capital is the most expensive money" and when founders s…
After four decades at the intersection of science, industry, and strategy — from the DKFZ bench to 14 years in pharma R&D to two decades writing the EY Biotech Report — Dr. Siegfried Bialojan has watched German biotech ask the same question for 25 years: why doesn't the money show up? In this e…
Welcome back to Transcribed, the podcast where we unpack the minds building the future of biotech. Today's guest, Professor Dr. Kerstin Goepfrich, is asking one of the most fundamental questions in all of science: what is life, and can we build it from scratch? As a full professor at Heidelberg Uni…
As a founder and CEO of Accelerated Biosciences, Yuta Lee made an unlikely leap from a career in finance and insurance to building one of the most unusual stem cell platforms in regenerative medicine. He's commercializing a cell type discovered by his own father, one that might hold the key to figh…
As co-founder of Renatrix, Dr. Ahed Almalla is building a future where cells "feel at home" — using advanced biomaterials to create 3D microenvironments that better mimic human biology. In this episode, she shares her incredible journey from war-torn Aleppo to founding a biotech startup …
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Transcribed است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.